e-learning
resources
Copenhagen 2005
Sunday 18.09.2005
Assessment and intervention from primary care centre to hospital
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Predictive validity of SF-36 general health (GH) scale for COPD exacerbation
M. Parshall, D. Mapel, A. Williams, L. Rice (Albuquerque, United States Of America; Greenford / Uxbridge, United Kingdom)
Source:
Annual Congress 2005 - Assessment and intervention from primary care centre to hospital
Session:
Assessment and intervention from primary care centre to hospital
Session type:
Oral Presentation
Number:
259
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Parshall, D. Mapel, A. Williams, L. Rice (Albuquerque, United States Of America; Greenford / Uxbridge, United Kingdom). Predictive validity of SF-36 general health (GH) scale for COPD exacerbation. Eur Respir J 2005; 26: Suppl. 49, 259
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
High COPD assessment test (CAT) score is associated with unscheduled health care utilization
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
Change in the COPD assessment test (CAT) score as predictor of short-term evolution of patients admitted for an exacerbation of COPD
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
The health status burden of exacerbation in COPD as measured using the EQ-5D
Source: Eur Respir J 2002; 20: Suppl. 38, 249s
Year: 2002
COPD related fatigue (COPD-RF) as a patient centred outcome tool in COPD: Various predictors and its correlation with other outcome parameters
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016
TENOR risk score predicts healthcare in adults with severe or difficult-to-treat asthma
Source: Eur Respir J 2006; 28: 1145-1155
Year: 2006
Measurement of COPD’s impact using the COPD assessment test (CAT) and symptom assessment differences between patients and family members
Source: Annual Congress 2013 –Factors associated with outcomes in COPD
Year: 2013
Health status and psychological assessments
Source: Annual Congress 2007 - PG6 - COPD: comprehensive clinical assessment and pharmacological and nonpharmacological therapy
Year: 2007
Development and first validation of the COPD Assessment Test
Source: Eur Respir J 2009; 34: 648
Year: 2009
Effects of post exacerbation pulmonary rehabilitation (PEPR) on exercise tolerance, quality of life (QoL), anxiety, depression and healthcare utilisation
Source: International Congress 2015 – Physical activity, exercise and rehabilitation in COPD and beyond
Year: 2015
Loneliness and lack of social support severely influences patients’ quality of life. Secondary findings from our focusgroup study in asthma and COPD patients
Source: International Congress 2016 – Best abstracts in COPD management
Year: 2016
Validity of COPD assessment test (CAT) in patients with cardiovascular co-morbidities
Source: Annual Congress 2013 –Guidelines and exacerbations
Year: 2013
Repeated hospitalizations in patients and chronic respiratory failure due to COPD are best predicted by health status (QoL) and effort tolerance
Source: Eur Respir J 2003; 22: Suppl. 45, 575s
Year: 2003
Baseline symptom scores and future risk of severe exacerbation: The SPARK study
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015
Fatigue and decreased health can predict mortality in COPD
Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Year: 2013
Validation of the COPD severity score for use in primary care: the NEREA study
Source: Eur Respir J 2009; 33: 519-527
Year: 2009
The outcome of patients with COPD admitted to UK hospitals with an exacerbation. Results from the RCP/BTS national COPD audit
Source: Annual Congress 2005 - COPD - acute exacerbations
Year: 2005
The effect of unit organisation and resources on outcomes of hospital admission for COPD exacerbations
Source: Annual Congress 2005 - COPD - acute exacerbations
Year: 2005
Profiling hospital performance to monitor the quality of care: the case of COPD
Source: Eur Respir J 2010; 35: 1031-1038
Year: 2010
Comparing the prevalence of depression and anxiety in patients admitted with an exacerbation of COPD using two scoring systems
Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations
Year: 2015
Asthma control questionnaire score (ACQ-5) predicts future risk of exacerbations
Source: Annual Congress 2009 - Aspects of clinical asthma
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept